Anteroventral third ventricle lesions attenuate pressor responses to serotonin in anesthetized rats

Brain Research

Volumn 714, Issue 1-2, 1996, Pages 104-110

  Muntzel, Martin S ^a,c   Lewis, Stephen J ^a   Johnson, Alan Kim ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b E11 SSH   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Anteroventral third ventricle (AV3V) lesion; Blood pressure; Central nervous system; Serotonin

Indexed keywords

METHYLATROPINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BRAIN INJURY; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

ANIMALS; BLOOD PRESSURE; CEREBRAL VENTRICLES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0029920747     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01503-5     Document Type: Article

References (40)

1. 2 receptor agonist, in conscious rats, Eur. J. Pharmacol., 175 (1990) 323-332.
2. 2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats, J. Pharmacol. Exp. Ther., 243 (1987) 829-833.
3. 1C receptors to release vasopressin in anaesthetized rats, Br. J. Pharmacol., 107 (1992) 1020-1038.
4. Bagdy, G., Calogero, A.E., Murphy, D.L. and Szemerdi, K., Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats, Endocrinology, 125 (1989) 2664-2669.
5. Bagdy, G., Sved, A.F., Murphy, D.L. and Szemeredi, K., Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists, Eur. J. Pharmacol., 210 (1992) 285-289.
6. Brody, M.J. and Johnson, A.K., Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation, and hypertension. In: L. Martini and W.F. Ganong (Eds.), Frontiers in Neuroendocrinology, Vol. 6, Raven Press, New York, 1980, pp. 249-292.
7. Brody, M.J. and Johnson, A.K., Role of forebrain structures in models of experimental hypertension. In: Disturbances in the Neurogenic Control of the Circulation, Clinical Physiology Series, American Physiological Society, Williams and Wilkins, Baltimore, 1981, pp. 105-117.
8. Brownfield, M.S., Greathouse, J., Lorens, S.A., Armstrong, J., Urban, J.H. and Van de Kar, L.D., Neuropharmacological characterization of serotoninergic stimulation of vasopressin in conscious rats, Neuroendocrinology, 47 (1988) 277-283.
9. Buggy, J. and Johnson, A.K., Preoptic-hypothalamic periventricular lesions: thirst deficits and hypernatremia, Am. J. Physiol., 233 (1977) R44-R52.
10. 2-MSH), Brain Res., 444 (1988) 177-180.
11. Chandra, M. and Chandra, N., Serotonergic mechanisms in hypertension, Int. J. Cardiol., 42 (1993) 189-196.
12. Dabiré, H., Cherqui, C., Safar, M. and Schmitt, H., Haemodynamic aspects and serotonin, Clin. Physiol. Biochem., 3 (Suppl. 3) (1990) 56-63.
13. Dalton, D.W., The cardiovascular effects of centrally administered 5-hydroxytryptamine in the conscious normotensive and hypertensive rat, J. Autonom. Pharmacol., 6 (1986) 67-75.
14. 2 agonist 1-(2,5-dimethoxy-4-iodphenyl)-2-aminopropane, modify cardiovascular function through different mechanisms, J. Pharmacol. Exp. Ther., 259 (1991) 1027-1034.
15. Fink, G.D., Haywood, J.R., Bryan, J., Packwood, W. and Brody, M.J., Central site for pressor activity of blood-borne angiotensin in the rat, Am. J. Physiol., 239 (1980) R358-R361.
16. Fuller, R.W., Kurz, K.D., Mason, N.R. and Cohen, M.L., Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67, Eur. J. Pharmacol., 125 (1986) 71-77.
17. Gibbs, D.M. and Vale, W., Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood, Brain Res., 280 (1983) 176-179.
18. Iovino, M. and Steardo, L., Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat, Eur. J. Pharmacol., 113 (1985) 99-103.
19. Johnson, A.K. and Gross, P.M., Sensory circumventricular organs and brain homeostatic pathways, FASEB J., 7 (1993) 678-686.
20. Johnson, A.K., Hoffman, W.E. and Buggy, J., Attenuated pressor responses to intracranially injected stimuli and altered antidiuretic activity following preoptic-hypothalamic periventricular ablation, Brain Res., 157 (1978) 161-166.
21. Johnson, A.K., Schoun, J., NcNeill, J.R. and Mohring, J., Periventricular tissue of the anteroventral third ventricle (AV3V): a role for the control of vasopressin (VP) release, Federation Proc., 39 (1980) 986.
22. Kalkman, H.O., Engel, G. and Hoyer, D., Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats, J. Hypertens., 2 (Suppl. 3) (1984) 143-145.
23. 2 receptor agonists increase spontaneous sympathetic nerve discharge, Eur. J. Pharmacol., 151 (1988) 113-116.
24. Meller, S.T., Lewis, S.J., Brody, M.J. and Gebhart, G.F., Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. Role of 5-HT receptor subtypes, Brain Res., 585 (1992) 71-86.
25. Miselis, R.R., Shapiro, R.E. and Hand, P.J., Subfornical organ efferents to neural systems for control of body water, Science, 205 (1979) 1022-1025.
26. Montes, R. and Johnson, A.K., Efferent mechanisms mediating renal sodium and water excretion induced by centrally administered serotonin, Am. J. Physiol., 259 (1990) R1267-R1273.
27. Muntzel, M.S., Morgan, D.A., Mark, A.L. and Johnson, A.K., Intracerebroventricular administration of insulin produces nonuniform increases in sympathetic nerve activity, Am. J. Physiol., 267 (1994) R1350-R1355.
28. Pérgola, P.E. and Alper, R.H., Pharmacological evidence that circumventricular organs may participate in the pressor effect of central serotonin, Eur. J. Pharmacol., 203 (1991) 145-148.
29. Pérgola, P.E. and Alper, R.H., Effects of central serotonin on autonomie control of heart rate in intact and baroreceptor deficient rats, Brain Res., 582 (1992) 215-220.
30. Petersen, J.S., Hinojosa-Laborde, C. and DiBona, G.F., Sympathoinhibitory responses to 2-methylserotonin during changes in sodium intake, Hypertension, 21 (1993) 1000-1004.
31. Sanders, B.J., Knardahl, S. and Johnson, A.K., Lesions of the anteroventral third ventricle and development of stress-induced hypertension in the borderline hypertensive rat, Hypertension, 13 (1989) 817-821.
32. Saxena, P.R. and Villalon, C.M., 5-Hydroxytryptamine: a chameleon in the heart, Trends Pharmacol. Sci., 12 (1991) 223-227.
33. Silverman, A.J., Hoffman, D.L. and Zimmerman, E.A., The descending afferent connections of the paraventricular nucleus of the hypothalamus (PVN), Brain Res. Bull., 6 (1981) 47-61.
34. Smits, J.F. and Struyker-Boudier, H.A., Intrahypothalamic serotonin and cardiovascular control in rats, Brain Res., 111 (1976) 422-427.
35. Steardo, L. and Iovino, M., Vasopressin release after enhanced serotonergic transmission is not due to activation of the peripheral renin-angiotensin system, Brain Res., 382 (1986) 145-148.
36. Takahashi, H., Cardiovascular and sympathetic responses to intracarotid and intravenous injections of serotonin in rats, Naunyn-Schmiedebergs Arch. Pharmacol., 329 (1985) 222-226.
37. Takeuchi, Y. and Sano, Y., Serotonin distribution in the circumventricular organs of the rat: an immunohistochemical study, Anat. Embryol., 167 (1983) 311-319.
38. Van de Kar, L.D., Wilkinson, C.W. and Ganong, W.F., Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats, J. Pharmacol. Exp. Ther., 219 (1981) 85-90.
39. 3mediated reflex in rats, Am. J. Physiol., 263 (1993) H1871-H1877.
40. Wolf, W.A., Kuhn, D.M. and Lovenberg, W., Pressor effects of dorsal raphe stimulation and intrahypothalamic application of serotonin in the spontaneously hypertensive rat, Brain Res., 208 (1981) 192-197.